In the case of breast cancer, where certain ERBB4 isoforms activate YAP target genes to promote cell proliferation and invasion, SSOs may be used to steer splicing towards the production of ERBB4 isoforms that do not result in YAP transcriptional output. The gene discussed is YAP1; the disease is breast cancer.